T2 Biosystems (NASDAQ:TTOO – Get Free Report) announced its quarterly earnings data on Monday. The medical equipment provider reported ($0.66) EPS for the quarter, topping analysts’ consensus estimates of ($0.97) by $0.31, Yahoo Finance reports. The business had revenue of $1.95 million for the quarter. T2 Biosystems updated its FY 2024 guidance to EPS.
T2 Biosystems Price Performance
Shares of NASDAQ:TTOO traded up $0.10 during midday trading on Wednesday, reaching $4.99. 58,219 shares of the company’s stock were exchanged, compared to its average volume of 271,725. T2 Biosystems has a 12 month low of $2.60 and a 12 month high of $70.00. The company’s 50 day simple moving average is $5.11 and its two-hundred day simple moving average is $4.47.
Analysts Set New Price Targets
A number of research firms have recently weighed in on TTOO. Canaccord Genuity Group raised their price target on T2 Biosystems from $3.00 to $5.00 and gave the stock a “hold” rating in a research note on Tuesday. StockNews.com raised shares of T2 Biosystems to a “sell” rating in a research report on Tuesday.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
See Also
- Five stocks we like better than T2 Biosystems
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.